Engineered Nanoparticle Applications for Recombinant Influenza Vaccines.
Mol Pharm. 2021 Feb 1;18(2):576-592. doi: 10.1021/acs.molpharmaceut.0c00383. Epub 2020 Aug 17.
Mol Pharm. 2021.
PMID: 32787280
Free PMC article.
Review.